Common-Size Income Statement
Paying user area
Try for free
Abiomed Inc. pages available for free this week:
- Statement of Comprehensive Income
- Analysis of Profitability Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Capital Asset Pricing Model (CAPM)
- Selected Financial Data since 2005
- Current Ratio since 2005
- Total Asset Turnover since 2005
- Price to Earnings (P/E) since 2005
- Price to Operating Profit (P/OP) since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abiomed Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Abiomed Inc., common-size consolidated income statement
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
| Income statement item | Description | The company |
|---|---|---|
| Income from operations | The net result for the period of deducting operating expenses from operating revenues. | Abiomed Inc. income from operations as a percentage of revenue decreased from 2020 to 2021 and from 2021 to 2022. |
| Income before income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Abiomed Inc. income before income taxes as a percentage of revenue increased from 2020 to 2021 but then decreased significantly from 2021 to 2022. |
| Net income | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Abiomed Inc. net income as a percentage of revenue increased from 2020 to 2021 but then decreased significantly from 2021 to 2022. |